Highlights the risk of sarcopenic obesity and underscores the critical need for strength training and protein to preserve skeletal muscle during weight loss, especially in women over 40
To address this gap in coverage for GLP-1s to treat obesity, CMS is launching a model called BALANCE (Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth) under which CMS will negotiate pricing and coverage rules for GLP-1s, with the aim of expanding access to these medications and lifestyle interventions to support weight loss
The result: patients eat significantly less, lose weight, and experience improvements in blood sugar control
We encourage you to discuss all medical issues with your personal physicians and to seek in-person care when appropriate
For most research contexts, 9 mg therefore represents a more favourable efficacy-to-tolerability balance than 12 mg
Without proper treatment, intestinal blockages can be dangerous and even deadly